Sign in to view content

PRN cycles of three monthly anti-VEGF injections in neovascular AMD: 12 and 24 months results.

Touka Banaee, MD

Video
Published 2019

Related

Episode 23: CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD with Dr. Peter Kertes
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Apples and Oranges: "Real-World" Outcomes Differ From Clinical Trial Outcomes Because "Real-World" Patients Differ From Clinical Trial Patients
Franco M. Recchia, MD
Annual Meeting Talks
2021
Prevalence and Risk Factors for Early Hydroxychloroquine Retinopathy
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more